Zhengye Biotechnology Holding Limited

ZYBT

Healthcare|Drug Manufacturers - Specialty & Generic|CN

$1.50

+0.12 (+8.70%)

DCF Value

$0.44

Tangible Book / Share

$5.32

Cash / Share

$1.09

About

Zhengye Biotechnology Holding Limited specializes in the creation, manufacturing, and commercialization of animal health immunizations. The company primarily supplies the Chinese agricultural sector with vaccines tailored for a broad spectrum of farm animals, including swine, bovines, goats, ovines, and poultry. Additionally, its product range encompasses inoculations for canines. Beyond its domestic reach, the firm also distributes its offerings to international markets, notably exporting to Vietnam, Pakistan, and Egypt. Established in 2004, this enterprise bases its principal operations in Jilin, China, and operates as a subsidiary entity of Securingium Holding Limited.

Stock Price

-29.2%(1Y)

+30.4%

-20.6%

+58.0%

YTD

+30.4%

-27.5%

-69.1%

Pipeline Summary

0 total trials

Phase 1

Phase 2

Phase 3

Phase 4

Key Facts

Market Cap$71.1M

Employees0

CEOSonglin Song

IPO DateJan 7, 2025

Beta-2.30

52-Week Range$0.6155 – $8.01

Avg Volume4,028,791

ExchangeNASDAQ

Websitejlzybio.com

Ownership

Float9.3%

Shares Outstanding47.4M

Recent Insider Trades

Han ZhenfaOTHER

Jun 25, 20260 shares

Han ZhenfaOTHER

Jun 25, 20260 shares

Han ZhenfaOTHER

Jun 25, 20260 shares

Cheng Yuhong (nmn)OTHER

Jun 25, 20260 shares

Song SonglinOTHER

Jun 25, 20260 shares

Peers

APYXApyx Medical Corporation

$123.4M

ATOSAtossa Therapeutics, Inc.

$21.2M

CRDLCardiol Therapeutics Inc.

$120.1M

EXOZeXoZymes, Inc.

$40.8M

IXHLIncannex Healthcare Limited

$26.8M

ONCYOncolytics Biotech Inc.

$44.1M

PDEXPro-Dex, Inc.

$202.1M

SERASera Prognostics, Inc.

$84.3M

Data last updated: Nov 9, 2026, 04:42 AM